Scinvivo
Pre-clinicalScinvivo aims to revolutionize cancer diagnostics by providing the medical professionals with the next gen in vivo imaging platform.
Founded
2009
Focus
OncologyDrug Delivery
About
Scinvivo aims to revolutionize cancer diagnostics by providing the medical professionals with the next gen in vivo imaging platform.
Funding History
2Total raised: $1.7M
Grant$500KEuropean Innovation CouncilJun 15, 2021
Seed$1.2MUndisclosedJun 15, 2020
Company Info
TypePrivate
Founded2009
LocationLeiden, Netherlands
StagePre-clinical
Contact
SIMILAR COMPANIES
2-BBB Medicines
Pre-clinical · Leiden
Batavia Biosciences
Pre-clinical · Leiden
Bilthoven Biologicals
Pre-clinical · Bilthoven
Agendia
Pre-clinical · Amsterdam
Alloksys Life Sciences
Phase 2 · Wageningen
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile